AUTUMN BURNS: Open Payments
NPI 1467891838 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 51 payments from 14 companies in 2025. Trend: 2023 $82 · 2024 $118 · 2025 $1,092
Food & beverage: $1,058Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $230 |
| Amgen Inc. | 10 | $181 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| GENZYME CORPORATION | 4 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Grifols USA, LLC | 3 | $100 |
| Lilly USA, LLC | 2 | $37 |
| Insmed, Inc. | 1 | $30 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, AIRSUPRA, Prolastin-C Liquid, TRELEGY ELLIPTA, ZEPBOUND, Arikayce.
Industry payments across AL — which companies pay providers there.
